Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis - PubMed (original) (raw)
Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis
P L Fidel Jr et al. Infect Immun. 1994 Mar.
Abstract
It has been postulated that systemic cell-mediated immunity (CMI) is an important host defense factor against recurrent vaginal infections caused by Candida albicans. Using an estrogen-dependent murine model of vaginal candidiasis, we have previously shown that mice inoculated vaginally with C. albicans acquire a persistent vaginal infection and develop Candida-specific Th1-type systemic CMI. In the present study, experimental vaginitis was monitored in the presence of preinduced systemic Candida-specific CMI. Mice immunized systemically with C. albicans culture filtrate antigens (CaCF) in complete Freund's adjuvant (CFA) had Th1-type reactivity similar to that of vaginally infected mice. CaCF given to mice intravenously induced Candida-specific suppressor T (Ts) cells. Mice preimmunized with CaCF-CFA and given a vaginal inoculum of C. albicans had positive delayed-type hypersensitivity (DTH) reactivity from the time of vaginal inoculation through 4 weeks. Conversely, mice infected in the presence of Ts cells had significantly reduced DTH responses throughout the 4-week period in comparison with naive infected mice. However, the presence of Th1-type Candida-specific DTH cells or Ts cells, either induced in mice prior to vaginal inoculation or adoptively transferred at the time of inoculation, had no effect on the vaginal Candida burden through 4 weeks of infection. A similar lack of effects was obtained in animals with lower Candida population levels resulting from a reduction in or absence of exogenous estrogen. These results suggest that systemic Th1-type CMI demonstrable with CaCF is unrelated to protective events at the level of the vaginal mucosa.
Similar articles
- Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
Fidel PL Jr, Lynch ME, Sobel JD. Fidel PL Jr, et al. Infect Immun. 1993 Oct;61(10):4202-7. doi: 10.1128/iai.61.10.4202-4207.1993. Infect Immun. 1993. PMID: 8406809 Free PMC article. - Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.
Fidel PL Jr, Lynch ME, Sobel JD. Fidel PL Jr, et al. Infect Immun. 1993 May;61(5):1990-5. doi: 10.1128/iai.61.5.1990-1995.1993. Infect Immun. 1993. PMID: 8097493 Free PMC article. - Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.
Fidel PL Jr, Lynch ME, Conaway DH, Tait L, Sobel JD. Fidel PL Jr, et al. Infect Immun. 1995 Feb;63(2):547-53. doi: 10.1128/iai.63.2.547-553.1995. Infect Immun. 1995. PMID: 7822020 Free PMC article. - Immunity to Candida.
Fidel PL Jr. Fidel PL Jr. Oral Dis. 2002;8 Suppl 2:69-75. doi: 10.1034/j.1601-0825.2002.00015.x. Oral Dis. 2002. PMID: 12164664 Review. - The protective immune response against vaginal candidiasis: lessons learned from clinical studies and animal models.
Fidel PL Jr. Fidel PL Jr. Int Rev Immunol. 2002 Nov-Dec;21(6):515-48. doi: 10.1080/08830180215015. Int Rev Immunol. 2002. PMID: 12650240 Review.
Cited by
- Recurrent Vulvovaginal Candidiasis: Could It Be Related to Cell-Mediated Immunity Defect in Response to Candida Antigen?
Talaei Z, Sheikhbahaei S, Ostadi V, Ganjalikhani Hakemi M, Meidani M, Naghshineh E, Yaran M, Emami Naeini A, Sherkat R. Talaei Z, et al. Int J Fertil Steril. 2017 Oct;11(3):134-141. doi: 10.22074/ijfs.2017.4883. Epub 2017 Aug 27. Int J Fertil Steril. 2017. PMID: 28868834 Free PMC article. - Chronic vulvovaginal Candida hypersensitivity: An underrecognized and undertreated disorder by allergists.
Bernstein JA, Seidu L. Bernstein JA, et al. Allergy Rhinol (Providence). 2015 Jan;6(1):44-9. doi: 10.2500/ar.2015.6.0113. Allergy Rhinol (Providence). 2015. PMID: 25860170 Free PMC article. - Prospects for development of a vaccine to prevent and control vaginal candidiasis.
Fidel PL Jr, Cutler JE. Fidel PL Jr, et al. Curr Infect Dis Rep. 2011 Feb;13(1):102-7. doi: 10.1007/s11908-010-0143-y. Curr Infect Dis Rep. 2011. PMID: 21308461 Free PMC article. - Patterns of Expression of Vaginal T-Cell Activation Markers during Estrogen-Maintained Vaginal Candidiasis.
Al-Sadeq A, Hamad M, Abu-Elteen K. Al-Sadeq A, et al. Allergy Asthma Clin Immunol. 2008 Dec 15;4(4):157-63. doi: 10.1186/1710-1492-4-4-157. Epub 2008 Dec 15. Allergy Asthma Clin Immunol. 2008. PMID: 20525139 Free PMC article. - Candida infections of the genitourinary tract.
Achkar JM, Fries BC. Achkar JM, et al. Clin Microbiol Rev. 2010 Apr;23(2):253-73. doi: 10.1128/CMR.00076-09. Clin Microbiol Rev. 2010. PMID: 20375352 Free PMC article. Review.
References
- Proc R Soc Med. 1977;70 Suppl 4:3-6 - PubMed
- Immunol Today. 1988 Sep;9(9):268-74 - PubMed
- J Immunol. 1991 Sep 15;147(6):1773-8 - PubMed
- Infect Immun. 1991 Dec;59(12):4647-54 - PubMed
- Am J Obstet Gynecol. 1992 Mar;166(3):887-90 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources